首页> 外文期刊>Oxidative Medicine and Cellular Longevity >Immunotherapy Using Oxygenated Water and Tumor-Derived Exosomes Potentiates Antitumor Immune Response and Attenuates Malignancy Tendency in Mice Model of Breast Cancer
【24h】

Immunotherapy Using Oxygenated Water and Tumor-Derived Exosomes Potentiates Antitumor Immune Response and Attenuates Malignancy Tendency in Mice Model of Breast Cancer

机译:使用含氧水和肿瘤衍生的外泌体的免疫疗法增强了抗肿瘤免疫应答并衰减乳腺癌小鼠模型中的恶性趋势

获取原文
           

摘要

Breast cancer is one of the most common type of tumor and the leading cause of death in the world’s female population. Various therapeutic approaches have been used to treat tumors but have not led to complete recovery and have even damaged normal cells in the body. Moreover, metastatic tumors such as breast cancer are much more resistant to treatment, and current treatments have not been very successful in treating them and remain a challenge. Therefore, new approaches should be applied to overcome this problem. Given the importance of hypoxia in tumor survival, we aimed to test the antitumor effects of oxygenated water to decrease hypoxia along with tumor-derived exosomes to target tumor. The purpose of administering oxygenated water and tumor exosomes was to reduce hypoxia and establish an effective immune response against tumor antigens, respectively. For this purpose, the breast cancer mice model was induced using the 4T1 cell line in Balb/c mice and treated with oxygenated water via an intratumoral (IT) and/or intraperitoneal (IP) route and/or exosome (TEX). Oxygenation via the IT+IP route was more efficient than oxygenation via the IT or IP route. The efficiency of oxygenation via the two routes along with TEX led to the best therapeutic outcome. Antitumor immune responses directed by TEX became optimized when systemic (IP) and local (IT) oxygenation was applied compared to administration of TEX alone. Results demonstrated a significant reduction in tumor size and the highest levels of IFN- γ and IL-17 and the lowest levels of IL-4 FoxP3, HIF-1 α , VEGF, MMP-2, and MMP-9 in the IT+IP+TEX-treated group. Oxygenated water on the one hand could reduce tumor size, hypoxia, angiogenesis, and metastasis in the tumor microenvironment and on the other hand increases the effective immune response against the tumor systemically. This therapeutic approach is proposed as a new strategy for devising vaccines in a personalized approach.
机译:乳腺癌是世界上最常见的肿瘤类型之一,是世界女性人口中死亡的主要原因之一。各种治疗方法已被用于治疗肿瘤,但没有导致完全恢复,并且甚至在体内损坏正常细胞。此外,乳腺癌如乳腺癌的转移性肿瘤要耐药得多,并且目前的治疗在治疗它们并且仍然是一个挑战方面并没有非常成功。因此,应采用新方法来克服这个问题。鉴于缺氧在肿瘤存活中的重要性,我们旨在测试含氧水的抗肿瘤作用,将缺氧与靶肿瘤的肿瘤衍生的外泌体减少。施用含氧水和肿瘤外泌体的目的是减少缺氧并分别对肿瘤抗原的有效免疫应答。为此目的,使用BALB / C小鼠中的4T1细胞系诱导乳腺癌小鼠模型,并通过肿瘤内(IT)和/或腹膜内(IP)途径和/或外出(TEX)处理含氧水。通过IT + IP途径的氧化比通过IT或IP途径更有效。通过两条路线的氧合效率以及TEX导致了最佳的治疗结果。通过单独应用全身(IP)和局部(IT)氧合时,通过Tex指示的抗肿瘤免疫应答被优化。结果表明肿瘤大小和IFN-γ和IL-17的最高水平的显着降低以及IT-4 Foxp3,HIF-1α,VEGF,MMP-2和MMP-9的最低水平+ IP + Tex治疗组。一方面的含氧水可以降低肿瘤大小,缺氧,血管生成和转移,另一方面,在系统性上增加对肿瘤的有效免疫应答。这种治疗方法被提出为以个性化方法设计疫苗的新策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号